Split History
ETFs Holding XTNT »    XTNT Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Xtant Medical Holdings develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. Co.'s products serve the needs of orthopedic and neurological surgeons. Co.'s biomaterial products include OsteoSponge®, OsteoSponge® SC, OsteoSelect® DBM putty, OsteoSelect Plus DBM putty, OsteoWrap®, OsteoSTX® and its line of 3Demin®products, as well as other allografts. Co.'s spinal implant product lines include Certex™ Spinal Fixation System, Spider® Cervical Plating System, Axle® Interspinous Fusion System, Silex® Sacroiliac Joint Fusion System, Xpress™ Minimally Invasive Pedicle Screw System, Fortex® Pedicle Screw System and Calix®. According to our XTNT split history records, Xtant Medical Holdings has had 1 split.
XTNT split history picture
Xtant Medical Holdings (XTNT) has 1 split in our XTNT split history database. The split for XTNT took place on February 14, 2018. This was a 1 for 12 reverse split, meaning for each 12 shares of XTNT owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 83.3333333333333 share position following the split.

When a company such as Xtant Medical Holdings conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the XTNT split history from start to finish, an original position size of 1000 shares would have turned into 83.3333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Xtant Medical Holdings shares, starting with a $10,000 purchase of XTNT, presented on a split-history-adjusted basis factoring in the complete XTNT split history. XTNT split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 07/01/2010
End date: 11/15/2019
Start price/share: $42.00
End price/share: $1.86
Dividends collected/share: $0.00
Total return: -95.57%
Average Annual Total Return: -28.27%
Starting investment: $10,000.00
Ending investment: $442.95
Years: 9.38
Date Ratio
02/14/20181 for 12
XTNT is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ZGNX Split History
ZLCS Split History
ZSAN Split History
A Split History
AAC Split History
ABC Split History
ABIO Split History
ABMD Split History
ABT Split History
ABV Split History

TRACON Pharmaceuticals (TCON)
SELLAS Life Sciences Group, Inc. (SLS)
Tonix Pharmaceuticals Holding Corp. (TNXP)
Camber Energy, Inc. (CEI)
Cancer Genetics, Inc. (CGIX)
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 3X Shares (GUSH)
Kingold Jewelry, Inc. (KGJI)
Aethlon Medical, Inc. (AEMD)
Aberdeen Standard Physical Gold Shares ETF (SGOL)
Safe-T Group Ltd. (SFET)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

XTNT Insider Buying

XTNT Split History | www.SplitHistory.com | Copyright © 2013 - 2019, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.